GRS Advisors LLC lessened its position in Ventas, Inc. (NYSE:VTR - Free Report) by 93.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 37,287 shares of the real estate investment trust's stock after selling 560,541 shares during the quarter. Ventas comprises 0.2% of GRS Advisors LLC's holdings, making the stock its 25th largest position. GRS Advisors LLC's holdings in Ventas were worth $2,610,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in VTR. Cloud Capital Management LLC acquired a new position in Ventas in the 3rd quarter valued at $25,000. True Wealth Design LLC lifted its holdings in Ventas by 1,557.7% in the 3rd quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust's stock valued at $30,000 after purchasing an additional 405 shares in the last quarter. ORG Partners LLC boosted its stake in Ventas by 76.1% during the 3rd quarter. ORG Partners LLC now owns 456 shares of the real estate investment trust's stock worth $32,000 after purchasing an additional 197 shares during the last quarter. Wilmington Savings Fund Society FSB boosted its stake in Ventas by 65.5% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 455 shares of the real estate investment trust's stock worth $32,000 after purchasing an additional 180 shares during the last quarter. Finally, Elevation Point Wealth Partners LLC purchased a new stake in shares of Ventas during the second quarter worth $35,000. 94.18% of the stock is owned by institutional investors and hedge funds.
Ventas Trading Up 0.6%
VTR opened at $86.68 on Friday. The stock has a market capitalization of $41.17 billion, a PE ratio of 160.52, a P/E/G ratio of 2.10 and a beta of 0.73. Ventas, Inc. has a one year low of $60.15 and a one year high of $87.87. The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.67 and a current ratio of 0.67. The business's 50 day moving average price is $81.46 and its 200 day moving average price is $76.33.
Ventas (NYSE:VTR - Get Free Report) last issued its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.89 by ($0.74). Ventas had a return on equity of 2.09% and a net margin of 4.31%.The business had revenue of ($1,229.71) million during the quarter, compared to analysts' expectations of $1.53 billion. During the same quarter in the previous year, the company posted $0.81 earnings per share. The company's revenue was up 21.7% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. As a group, equities research analysts expect that Ventas, Inc. will post 3.4 EPS for the current year.
Ventas Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, April 16th. Investors of record on Tuesday, March 31st will be given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend is Tuesday, March 31st. This is a positive change from Ventas's previous quarterly dividend of $0.48. Ventas's dividend payout ratio is 355.56%.
Insider Buying and Selling
In other Ventas news, CEO Debra A. Cafaro sold 10,322 shares of the company's stock in a transaction dated Monday, February 2nd. The shares were sold at an average price of $77.66, for a total value of $801,606.52. Following the transaction, the chief executive officer owned 1,114,034 shares of the company's stock, valued at $86,515,880.44. This represents a 0.92% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CFO Robert F. Probst sold 29,930 shares of the stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $77.25, for a total transaction of $2,312,092.50. Following the transaction, the chief financial officer directly owned 138,434 shares of the company's stock, valued at approximately $10,694,026.50. This trade represents a 17.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 86,106 shares of company stock valued at $6,931,397. 0.80% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently commented on VTR shares. Argus set a $88.00 target price on shares of Ventas in a research report on Tuesday, February 10th. UBS Group restated a "neutral" rating and set a $85.00 price target on shares of Ventas in a research report on Monday, February 9th. Wells Fargo & Company upped their price objective on shares of Ventas from $80.00 to $88.00 and gave the company an "overweight" rating in a research note on Tuesday, November 25th. Weiss Ratings upgraded shares of Ventas from a "hold (c+)" rating to a "buy (b-)" rating in a report on Monday, December 29th. Finally, The Goldman Sachs Group restated a "buy" rating and set a $100.00 target price on shares of Ventas in a report on Monday, February 9th. Thirteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat, Ventas currently has a consensus rating of "Moderate Buy" and an average target price of $89.00.
Get Our Latest Analysis on Ventas
About Ventas
(
Free Report)
Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas' business model combines property ownership with active asset management and capital markets activity.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ventas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ventas wasn't on the list.
While Ventas currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report